Spero Therapeutics (SPRO) Capital Expenditures (2016 - 2021)
Spero Therapeutics (SPRO) reported Capital Expenditures of $12,000 for Q4 2020, down 90.7% from $129,000 a year earlier and down 76.5% from the prior quarter.
Powered by 
Analysis
Spero Therapeutics (SPRO) Capital Expenditures (2016 - 2021) Analysis & Trends
For FY2020, Spero Therapeutics posted Capital Expenditures of $157,000, down 50.0% from FY2019.
- Capital Expenditures has a five-year compound annual growth rate of -7.5% (FY2015 to FY2020).
- By year, Capital Expenditures came in at $314,000 in FY2019 (-87.1%), $2.44 million in FY2018, $27,000 in FY2017 (-96.7%) and $830,000 in FY2016 (+257.8%).
- The Q4 2020 figure ranks as the lowest quarterly Capital Expenditures in data going back to Q4 2016.
- Year over year, Capital Expenditures gained in 1 of the last five quarters, with an average decline of 14.1%.
- Per Business Quant data, the three quarters before Q4 2020 came in at $51,000 (Q3 2020), $15,000 (Q2 2020) and $79,000 (Q1 2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Spero Therapeutics | 68.40 Mn | -127.38 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | -39,000.00 |
| Dec 31, 2020 | 12,000.00 |
| Sep 30, 2020 | 51,000.00 |
| Jun 30, 2020 | 15,000.00 |
| Mar 31, 2020 | 79,000.00 |
| Dec 31, 2019 | 129,000.00 |
| Sep 30, 2019 | 17,000.00 |
| Jun 30, 2019 | 87,000.00 |
| Mar 31, 2019 | 81,000.00 |
| Dec 31, 2018 | 2.41 Mn |
| Dec 31, 2016 | 261,000.00 |
API Access
Spero Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SPRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "SPRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SPRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();